Catalyst Wire Dossier Catalyst Wire Dossier

HYLENEX RECOMBINANT

HYALURONIDASE · Antares Pharma, Inc.
Drug timelines are a Plus or Pro feature.

17 regulatory and trial events tracked for HYLENEX RECOMBINANT, covering 2006-06-09 to 2024-01-12. Get the full timeline:

Most recent: FDA Approved: HYLENEX RECOMBINANT — Supplemental Application (Antares Pharma, Inc.)

See pricing